Liquid Biopsy and 18F-FDG PET/CT Derived Parameters as Predictive Factors of Osimertinib Treatment in Advanced EGFR-Mutated NSCLC.
Leonetti A, Cervati V, Minari R, Scarlattei M, Verzè M, Peroni M, Pluchino M, Bonatti F, Perrone F, Mazzaschi G, Cosenza A, Gnetti L, Bordi P, Ruffini L, Tiseo M.
Leonetti A, et al. Among authors: ruffini l.
Clin Lung Cancer. 2024 Aug 6:S1525-7304(24)00154-2. doi: 10.1016/j.cllc.2024.07.016. Online ahead of print.
Clin Lung Cancer. 2024.
PMID: 39198088